Activity Overview
This educational activity is an archive of the live conference held on January 24, 2026.
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancer. Other health care professionals interested in the treatment of lung cancer are also invited to participate.
Learning Objectives
- Implement the latest evidence-based, guideline-preferred approaches to biomarker testing for determining treatment plans for patients with lung cancer
- Integrate emerging clinical trial evidence regarding the management of patients with lung cancer into personalized treatment plans